Eric Mark Green West Pharmaceutical Services Inc (WST) insider trading activity

WST Quotes by TradingView

Eric Mark Green is President, CEO and Board Chair of WEST PHARMACEUTICAL SERVICES INC. Currently has a direct ownership of 161,898 shares of WST, which is worth approximately $52.4 Million. The most recent transaction as insider was on Aug 06, 2024, when has been sold 30,732 shares (Common Stock) at a price of $304.71 per share, resulting in proceeds of $9,364,347. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K
0% 3M change
15.17% 12M change
Total Value Held $52.4 Million

Eric Mark Green Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 06 2024
SELL
Open market or private sale
$9,364,347 $304.71 p/Share
30,732 Reduced 15.95%
161,898 Common Stock
Aug 06 2024
BUY
Exercise of conversion of derivative security
$2,190,696 $59.64 p/Share
36,732 Added 17.95%
167,898 Common Stock
May 07 2024
SELL
Open market or private sale
$24,198,900 $366.65 p/Share
66,000 Reduced 30.15%
152,908 Common Stock
May 07 2024
BUY
Exercise of conversion of derivative security
$4,388,250 $58.51 p/Share
75,000 Added 31.66%
161,908 Common Stock
Feb 27 2024
SELL
Open market or private sale
$23,077,900 $359.85 p/Share
64,132 Reduced 29.55%
152,908 Common Stock
Feb 27 2024
BUY
Exercise of conversion of derivative security
$4,196,314 $57.38 p/Share
73,132 Added 32.35%
152,908 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
6,567 Added 4.24%
148,202 Common Stock
Dec 06 2023
SELL
Bona fide gift
$3,361,400 $343.0 p/Share
9,800 Reduced 6.97%
130,774 Common Stock
Aug 08 2023
SELL
Open market or private sale
$17,376,040 $394.91 p/Share
44,000 Reduced 23.84%
140,574 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
$2,869,000 $57.38 p/Share
50,000 Added 21.32%
184,574 Common Stock
May 09 2023
SELL
Open market or private sale
$16,007,640 $363.81 p/Share
44,000 Reduced 24.64%
134,574 Common Stock
May 09 2023
BUY
Exercise of conversion of derivative security
$2,869,000 $57.38 p/Share
50,000 Added 21.87%
178,574 Common Stock
Mar 07 2023
SELL
Open market or private sale
$14,188,680 $322.47 p/Share
44,000 Reduced 25.5%
128,574 Common Stock
Mar 07 2023
BUY
Exercise of conversion of derivative security
$2,869,000 $57.38 p/Share
50,000 Added 26.92%
135,705 Common Stock
Feb 21 2023
BUY
Grant, award, or other acquisition
$4,533,650 $306.68 p/Share
14,783 Added 10.23%
129,705 Common Stock
Dec 05 2022
SELL
Open market or private sale
$10,525,680 $239.22 p/Share
44,000 Reduced 27.69%
114,922 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$2,869,000 $57.38 p/Share
50,000 Added 23.93%
158,922 Common Stock
Feb 22 2022
BUY
Grant, award, or other acquisition
$8,159,250 $369.13 p/Share
22,104 Added 16.87%
108,922 Common Stock
Feb 13 2022
SELL
Payment of exercise price or tax liability
$33,252 $391.2 p/Share
85 Reduced 0.1%
86,818 Common Stock
Feb 22 2021
BUY
Grant, award, or other acquisition
$4,844,172 $272.65 p/Share
17,767 Added 16.48%
90,053 Common Stock
Feb 14 2021
SELL
Payment of exercise price or tax liability
$27,049 $294.01 p/Share
92 Reduced 0.13%
72,286 Common Stock

Also insider at

ECL
ECOLAB INC. Basic Materials
EMG

Eric Mark Green

President, CEO and Board Chair
Exton, PA

Track Institutional and Insider Activities on WST

Follow WEST PHARMACEUTICAL SERVICES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on WST